Nef mutations in long-term non-progressors from former plasma donors infected with HIV-1 subtype B in China

Biomedical and Environmental Sciences

Volumn 21, Issue 6, 2008, Pages 485-491

  Wang, Shu Hua ^a,b   Xing, Hui ^a   He, Xiang ^a   Zhu, Feng Xia ^b   Meng, Zhe Feng ^a   Ruan, Yu Hua ^a   Shao, Yi Ming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b The General Hospital of Civil Aviation Administration of China   (China)

Author keywords

HIV 1; Long term nonprogressors; Nef; Secondary structure prediction; Sequence mutations

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 59849121969     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(09)60007-6     Document Type: Article

References (26)

1. Valdez H, Carlson N L, Post A B, et al. (2002). HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens. AIDS 16(8), 1113-1118.
2. Paroli M, Propato A, Accapezzato D, et al. (2001). The immunology of HIV-infected long-term non-progressors - a current view. Immunol Lett 79, 127-129.
3. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77(21), 11708-11717.
4. Das S R, Jameel S (2005). Biology of the HIV Nef protein. Indian J Med Res 121(4), 315-332.
5. Arold S T, Baur A S (2001). Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 26(6), 356-363.
6. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200(6), 749-759.
7. + T cells: serial killers condemned to die? Curr HIV Res 2(2), 153-162.
8. +T cell responses in Chinese population. Chin J Microbiol Immunol 26, 549-552.
9. Centers for Disease Control (1993). Morb Mortal Wkly Rep 41, 1-19.
10. Min Wei, Hui Xing, Yiming Shao, et al. (2004). Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor. AIDS 18(13), 1863-1865.
11. + T cells: correlation with viral load. J Virol 78(7), 3233-3243.
12. Korber B, Walker B D, Brander C R, et al. (2005). HIV molecular immunology database. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N Mex.
13. 13.Geyer M, Fackler O T, Peterlin B M (2001). Structure - function relationships in HIV-1 Nef. EMBO Rep 2(7), 580-585.
14. 14.Peng B, Robert-Guroff M (2001). Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation. Immunol Lett 78(3), 195-200.
15. 15.Blagoveshchenskaya A D, Thomas L, Feliciangeli S F, et al. (2002). HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111(6), 853-866.
16. Stumptner-Cuvelette P, Morchoisne S, Dugast M, et al. (2001). HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci USA 98(21), 12144-12149.
17. I7. Stumptner-Cuvelette P, Jouve M, Helft J, et al. (2003). Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase. Mol Biol Cell 14(12), 4857-4870.
18. Schindler M, Wurfl S, Benaroch P, et al. (2003). Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J Virol 77(19), 10548-10556.
19. Bell I, Schaefer T M, Trible R P, et al. (2001). Down-modulation of the costimulatory molecule, CD28, is a conserved activity of multiple SIV Nefs and is dependent on histidine 196 of Nef. Virology 283(1), 148-158.
20. Swigut T, Shohdy N, Skowronski J (2001). Mechanism for down-regulation of CD28 by Nef. EMBO J 28(1), 1593-1604.
21. Cohen G B, Rangan V S, Chen B K, et al. (2000). The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation. J.Biol. Chem 275(30), 23097-23105.
22. Foster J L, Molina R P, Luo T, et al. (2001). Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates. J Virol 75 (4), 1672-1680.
23. Iafrate AJ, Bronson S, Skowronski J, et al. (1997). Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J 16(4), 673-684.
24. Kelleher A D, Long C, Holmes E C, et al. (2001). Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 193(3), 375-386.
25. Kirchhoff F, Easterbrook P J, Douglas N, et al. (1999). Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol 73(7), 5497-5508.
26. Miles L R, Agresta B E, Khan M B, et al. (2005). Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity. J Virol 79(11), 6859-6867.